BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Adinolfi LE, Zampino R, Restivo L, Lonardo A, Guerrera B, Marrone A, Nascimbeni F, Florio A, Loria P. Chronic hepatitis C virus infection and atherosclerosis: Clinical impact and mechanisms. World J Gastroenterol 2014; 20(13): 3410-3417 [PMID: 24707124 DOI: 10.3748/wjg.v20.i13.3410]
URL: https://www.wjgnet.com/1007-9327/full/v20/i13/3410.htm
Number Citing Articles
1
Hrvoje Roguljic, Vjera Nincevic, Kristina Bojanic, Lucija Kuna, Robert Smolic, Aleksandar Vcev, Dragan Primorac, Andrijana Vceva, George Y. Wu, Martina Smolic. Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An UpdateFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.678546
2
Amin R. Soliman, Rabab M. Ahmed, Mahmoud Soliman, Ahmed Abdallah, Bahaa Zayed. The effect of co-infection with hepatitis B and hepatitis C viruses on the prevalence of proteinuria and loss of renal function: a single-center experienceThe Egyptian Journal of Internal Medicine 2018; 30(4): 271 doi: 10.4103/ejim.ejim_51_18
3
Roger Bedimo, Oladapo Abodunde. Metabolic and Cardiovascular Complications in HIV/HCV-Co-infected PatientsCurrent HIV/AIDS Reports 2016; 13(6): 328 doi: 10.1007/s11904-016-0333-9
4
F. Fabrizi, R. Cerutti, F.M. Donato, P. Messa. La infección por VHB es un factor de riesgo de enfermedad renal crónica: revisión sistemática y metaanálisisRevista Clínica Española 2020;  doi: 10.1016/j.rce.2019.10.010
5
Luigi Adinolfi, Luca Rinaldi, Barbara Guerrera, Luciano Restivo, Aldo Marrone, Mauro Giordano, Rosa Zampino. NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic ManifestationsInternational Journal of Molecular Sciences 2016; 17(6): 803 doi: 10.3390/ijms17060803
6
T. Revuelto Artigas, N. Zaragoza Velasco, X. Gómez Arbones, T. Vidal Ballester, C. Piñol Felis, J.M. Reñe Espinet, A. Betriu Bars. Infección crónica por el virus de la hepatitis C: un factor de riesgo independiente para la ateromatosis subclínicaRevista Clínica Española 2019; 219(6): 293 doi: 10.1016/j.rce.2018.12.007
7
Luigi Elio Adinolfi, Emanuele Durante Mangoni, Aldo Marrone, Rosa Zampino, Luca Rinaldi. Liver Diseases2020; : 181 doi: 10.1007/978-3-030-24432-3_17
8
Fabrizio Fabrizi, Roberta Cerutti, Vivek Dixit, Piergiorgio Messa. The impact of antiviral therapy for HCV on kidney disease: a systematic review and meta-analysisNefrología 2020; 40(3): 299 doi: 10.1016/j.nefro.2019.07.007
9
Zobair M. Younossi, Maria Stepanova, Patrick Marcellin, Nezam Afdhal, Kris V. Kowdley, Stefan Zeuzem, Sharon L. Hunt. Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trialsHepatology 2015; 61(6): 1798 doi: 10.1002/hep.27724
10
Jose Gabriel Solis, Ervin Saul Enciso López, Aleida Bautista Santos, Juan Carlos Anda Garay, Jose Luis Calixto Rodríguez, Rosalba Moreno Alcántar, Luis Montiel López. Effect of Direct Antiviral Agents on Atherosclerosis in Patients with Chronic Hepatitis CArchives of Medical Research 2021;  doi: 10.1016/j.arcmed.2021.04.009
11
O.O. Olubamwo, A.O. Aregbesola, J. Miettola, J. Kauhanen, T.-P. Tuomainen. Hepatitis C and risk of coronary atherosclerosis – A systematic reviewPublic Health 2016; 138: 12 doi: 10.1016/j.puhe.2016.04.005
12
Kirat Gill, Hasmik Ghazinian, Richard Manch, Robert Gish. Hepatitis C virus as a systemic disease: reaching beyond the liverHepatology International 2016; 10(3): 415 doi: 10.1007/s12072-015-9684-3
13
Qi-tao Huang, Li-lin Hang, Mei Zhong, Yun-fei Gao, Man-ling Luo, Yan-hong Yu. Maternal HCV infection is associated with intrauterine fetal growth disturbanceMedicine 2016; 95(35): e4777 doi: 10.1097/MD.0000000000004777
14
Roberto Minutolo, Alessio Aghemo, Antonio Chirianni, Fabrizio Fabrizi, Loreto Gesualdo, Edoardo G. Giannini, Paolo Maggi, Vincenzo Montinaro, Ernesto Paoletti, Marcello Persico, Francesco Perticone, Salvatore Petta, Massimo Puoti, Giovanni Raimondo, Maria Rendina, Anna Linda Zignego. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN)Infection 2019; 47(1): 141 doi: 10.1007/s15010-018-1209-2
15
Andrea TASSI, Stefano GITTO, Chiara PIRAS, Carmela CURSARO, Tatiana ALICANDRO, Marzia MARGOTTI, Marco RIVI, Pietro ANDREONE. Cognitive, neurological and psychiatric disorders occurring in Hepatitis C Virus infectionMinerva Medica 2021; 112(2) doi: 10.23736/S0026-4806.21.07388-2
16
Núria Esforzado, José María Morales. Hepatitis C y trasplante renal: el tiempo de la erradicación del virus ha llegadoNefrología 2019; 39(5): 458 doi: 10.1016/j.nefro.2019.01.002
17
Chia-Chi Wang, Pin-Nan Cheng, Jia-Horng Kao. Systematic review: chronic viral hepatitis and metabolic derangementAlimentary Pharmacology & Therapeutics 2020; 51(2): 216 doi: 10.1111/apt.15575
18
Mirela Pavicic Ivelja, Ivo Ivic, Kresimir Dolic, Antonio Mestrovic, Nikola Perkovic, Stipan Jankovic, Rayaz A Malik. Evaluation of cerebrovascular reactivity in chronic hepatitis C patients using transcranial color DopplerPLOS ONE 2019; 14(6): e0218206 doi: 10.1371/journal.pone.0218206
19
Mohamed A. Abd El Hafez, Zeinab Abdel Aziz Kasemy. Effect of direct-acting antivirals on platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with hepatitis C virus-related thrombocytopeniaThe Egyptian Journal of Internal Medicine 2019; 31(3): 296 doi: 10.4103/ejim.ejim_14_19
20
Jose M. Morales, Fabrizio Fabrizi. Hepatitis C and its impact on renal transplantationNature Reviews Nephrology 2015; 11(3): 172 doi: 10.1038/nrneph.2015.5
21
F. Fabrizi, R. Cerutti, F.M. Donato, P. Messa. HBV infection is a risk factor for chronic kidney disease: Systematic review and meta-analysisRevista Clínica Española (English Edition) 2021;  doi: 10.1016/j.rceng.2019.10.014
22
Olubunmi O. Olubamwo, Ifeoma N. Onyeka, Juhani Miettola, Jussi Kauhanen, Tomi-Pekka Tuomainen. Hepatitis C as a risk factor for carotid atherosclerosis - a systematic reviewClinical Physiology and Functional Imaging 2016; 36(4): 249 doi: 10.1111/cpf.12229
23
Luigi Elio Adinolfi, Riccardo Nevola, Luca Rinaldi, Ciro Romano, Mauro Giordano. Chronic Hepatitis C Virus Infection and DepressionClinics in Liver Disease 2017; 21(3): 517 doi: 10.1016/j.cld.2017.03.007
24
H. Husseinzadeh, T. Chiasakul, P. A. Gimotty, B. Pukenas, R. Wolf, M. Kelty, E. Chiang, P. F. Fogarty, A. Cuker. Prevalence of and risk factors for cerebral microbleeds among adult patients with haemophilia A or BHaemophilia 2018; 24(2): 271 doi: 10.1111/hae.13398
25
José M. Ferro, Sofia Oliveira. Neurologic Manifestations of Gastrointestinal and Liver DiseasesCurrent Neurology and Neuroscience Reports 2014; 14(10) doi: 10.1007/s11910-014-0487-z
26
Jakob Van Herck, Jef Verbeek, Hannah van Malenstein, Wim Laleman, David Cassiman, Chris Verslype, Schalk van der Merwe, Ina Jochmans, Mauricio Sainz-Barriga, Diethard Monbaliu, Jacques Pirenne, Frederik Nevens. Liver-Related and Cardiovascular Outcome of Patients Transplanted for Nonalcoholic Fatty Liver Disease: A European Single-Center StudyTransplantation Proceedings 2021; 53(5): 1674 doi: 10.1016/j.transproceed.2021.02.025
27
Sha Li, Jian-Jun Li. PCSK9: A key factor modulating atherosclerosisJournal of Atherosclerosis and Thrombosis 2015; 22(3): 221 doi: 10.5551/jat.27615
28
Fabrizio Fabrizi, Roberta Cerutti, Vivek Dixit, Piergiorgio Messa. The impact of antiviral therapy for HCV on kidney disease: a systematic review and meta-analysisNefrología (English Edition) 2020; 40(3): 299 doi: 10.1016/j.nefroe.2020.06.005
29
Luigi Elio Adinolfi, Luca Rinaldi, Riccardo Nevola. Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments?World Journal of Gastroenterology 2018; 24(41): 4617-4621 doi: 10.3748/wjg.v24.i41.4617
30
Shih-Yi Lin, Cheng-Li Lin, Wei-Shan Chen, Cheng-Chieh Lin, Chih-Hsueh Lin, Wu-Huei Hsu, Chung Y Hsu, Chia-Hung Kao. Association Between Alcoholic Cirrhosis and Hemorrhagic Stroke: A Nationwide Population-based StudyAlcohol and Alcoholism 2019; 54(3): 302 doi: 10.1093/alcalc/agz025
31
Tracey G Simon, Adeel A Butt. Lipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomesWorld Journal of Gastroenterology 2015; 21(27): 8293-8303 doi: 10.3748/wjg.v21.i27.8293
32
Melissa Bello-Perez, Alberto Falco, Beatriz Novoa, Luis Perez, Julio Coll, Keivan Zandi. Hydroxycholesterol binds and enhances the anti-viral activities of zebrafish monomeric c-reactive protein isoformsPLOS ONE 2019; 14(1): e0201509 doi: 10.1371/journal.pone.0201509
33
T. Revuelto Artigas, N. Zaragoza Velasco, X. Gómez Arbones, T. Vidal Ballester, C. Piñol Felis, J.M. Reñe Espinet, A. Betriu Bars. Chronic hepatitis C infection: An independent risk factor for subclinical atheromatosisRevista Clínica Española (English Edition) 2019; 219(6): 293 doi: 10.1016/j.rceng.2019.02.008
34
Stefano Ballestri, Fabio Nascimbeni, Dante Romagnoli, Enrica Baldelli, Giovanni Targher, Amedeo Lonardo. Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the SpotlightInternational Journal of Molecular Sciences 2016; 17(3): 355 doi: 10.3390/ijms17030355
35
Stefano Gitto, Arrigo F.G. Cicero, Elisabetta Loggi, Marina Giovannini, Fabio Conti, Elena Grandini, Valeria Guarneri, Alessandra Scuteri, Giovanni Vitale, Carmela Cursaro, Claudio Borghi, Pietro Andreone. Worsening of Serum Lipid Profile after Direct Acting Antiviral TreatmentAnnals of Hepatology 2018; 17(1): 64 doi: 10.5604/01.3001.0010.7536
36
Lucija Virović Jukić, Dominik Kralj. Update on Hepatitis C2017;  doi: 10.5772/intechopen.70728
37
Abdul-Quddus Mohammed, Ranshaka Auckle, Hai-Ling Li, Si-Ling Xu, Lu Liu, Dong-Dong Zhao, Wen-Liang Che. Pegylated Interferon-α Plus Ribavirin Therapy Improves Left Ventricular Diastolic Dysfunction in Patients With Chronic Hepatitis C Attaining Sustained Virological ResponseThe American Journal of the Medical Sciences 2018; 355(6): 566 doi: 10.1016/j.amjms.2018.02.001
38
Alejandro Alvaro-Meca, Juan Berenguer, Asunción Díaz, Dariela Micheloud, Teresa Aldámiz-Echevarría, Chiara Fanciulli, Salvador Resino, Sarah L Pett. Stroke in HIV-infected individuals with and without HCV coinfection in Spain in the combination antiretroviral therapy eraPLOS ONE 2017; 12(6): e0179493 doi: 10.1371/journal.pone.0179493
39
Vicente Soriano, Juan Berenguer. Extrahepatic comorbidities associated with hepatitis C virus in HIV-infected patientsCurrent Opinion in HIV and AIDS 2015; 10(5): 309 doi: 10.1097/COH.0000000000000175
40
Laith Al-Rabadi, Terry Box, Girish Singhania, Catreena Al-Marji, Adhish Agarwal, Isaac Hall, Craig E. Gordon, Huy Tran. Rationale for treatment of hepatitis C virus infection in end-stage renal disease patients who are not kidney transplant candidatesHemodialysis International 2018; 22: S45 doi: 10.1111/hdi.12656
41
Christopher Dächert, Evgeny Gladilin, Marco Binder. Gene Expression Profiling of Different Huh7 Variants Reveals Novel Hepatitis C Virus Host FactorsViruses 2019; 12(1): 36 doi: 10.3390/v12010036
42
Maria Mazzitelli, Carlo Torti, Jolanda Sabatino, Greta Luana D’Ascoli, Chiara Costa, Vincenzo Pisani, Elena Raffetti, Salvatore De Rosa, Alessio Strazzulla, Alfredo Focà, Maria Carla Liberto, Ciro Indolfi. Evaluation of cardiac function by global longitudinal strain before and after treatment with sofosbuvir-based regimens in HCV infected patientsBMC Infectious Diseases 2018; 18(1) doi: 10.1186/s12879-018-3426-9
43
Tomohisa Nagano, Nobuyoshi Seki, Yoichi Tomita, Tomonori Sugita, Yuta Aida, Munenori Itagaki, Satoshi Sutoh, Hiroshi Abe, Akihito Tsubota, Yoshio Aizawa. Impact of Chronic Hepatitis C Virus Genotype 1b Infection on Triglyceride Concentration in Serum Lipoprotein FractionsInternational Journal of Molecular Sciences 2015; 16(9): 20576 doi: 10.3390/ijms160920576
44
Núria Esforzado, José María Morales. Hepatitis C and kidney transplant: The eradication time of the virus has arrivedNefrología (English Edition) 2019; 39(5): 458 doi: 10.1016/j.nefroe.2019.01.009
45
Fabrizio Fabrizi, Francesca M. Donato, Piergiorgio Messa. Association Between Hepatitis B Virus and Chronic Kidney Disease: a Systematic Review and Meta-analysisAnnals of Hepatology 2017; 16(1): 21 doi: 10.5604/16652681.1226813
46
Roberto Minutolo, Alessio Aghemo, Antonio Chirianni, Fabrizio Fabrizi, Loreto Gesualdo, Edoardo G. Giannini, Paolo Maggi, Vincenzo Montinaro, Ernesto Paoletti, Marcello Persico, Francesco Perticone, Salvatore Petta, Massimo Puoti, Giovanni Raimondo, Maria Rendina, Anna Linda Zignego. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN)Journal of Nephrology 2018; 31(5): 685 doi: 10.1007/s40620-018-0523-1
47
V. V. Tsvetkov, I. I. Tokin, S. A. Pozdnjakova. Clinical epidemiology of extrahepatic manifestations of chronic hepatitis C virus infectionMedical Council 2020; (21): 248 doi: 10.21518/2079-701X-2019-21-248-253
48
Hong-Juan Fu, Li-Bo Zhao, Ju-Jun Xue, Zhi-Xuan Wu, Yue-Ping Huang, Wei Liu, Zhan Gao. Elevated Serum Homocysteine (Hcy) Levels May Contribute to the Pathogenesis of Cerebral InfarctionJournal of Molecular Neuroscience 2015; 56(3): 553 doi: 10.1007/s12031-015-0497-6
49
Melissa Bello-Perez, Alberto Falco, Regla Medina-Gali, Patricia Pereiro, Jose Antonio Encinar, Beatriz Novoa, Luis Perez, Julio Coll. Neutralization of viral infectivity by zebrafish c-reactive protein isoformsMolecular Immunology 2017; 91: 145 doi: 10.1016/j.molimm.2017.09.005
50
Ferdinando Carlo Sasso, Pia Clara Pafundi, Alfredo Caturano, Raffaele Galiero, Erica Vetrano, Riccardo Nevola, Salvatore Petta, Anna Ludovica Fracanzani, Carmine Coppola, Vito Di Marco, Antonio Solano, Rosa Lombardi, Mauro Giordano, Antonio Craxi, Alessandro Perrella, Celestino Sardu, Raffaele Marfella, Teresa Salvatore, Luigi Elio Adinolfi, Luca Rinaldi. Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetesNutrition, Metabolism and Cardiovascular Diseases 2021; 31(8): 2345 doi: 10.1016/j.numecd.2021.04.016
51
Amedeo Lonardo, Stefano Ballestri, Giovanni Guaraldi, Fabio Nascimbeni, Dante Romagnoli, Stefano Zona, Giovanni Targher. Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVWorld Journal of Gastroenterology 2016; 22(44): 9674-9693 doi: 10.3748/wjg.v22.i44.9674
52
Mauro Viganò, Massimo Colombo. Extrahepatic Manifestations of Hepatitis C VirusGastroenterology Clinics of North America 2015; 44(4): 775 doi: 10.1016/j.gtc.2015.07.006
53
Fabrizio Fabrizi, Francesca M. Donato, Piergiorgio Messa. Association Between Hepatitis C Virus and Chronic Kidney Disease: A Systematic Review and Meta-AnalysisAnnals of Hepatology 2018; 17(3): 364 doi: 10.5604/01.3001.0011.7382
54
Fiona Marra, Christoph Höner zu Siederdissen, Saye Khoo, David Back, Michael Schlag, Sivi Ouwerkerk-Mahadevan, Ceyhun Bicer, Isabelle Lonjon-Domanec, Wolfgang Jessner, Maria Beumont-Mauviel, Ronald Kalmeijer, Markus Cornberg. Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor simeprevir and frequently used concomitant medicationsBritish Journal of Clinical Pharmacology 2018; 84(5): 961 doi: 10.1111/bcp.13519
55
Fan Z. Caprio, Chen Lin. Warlow's Stroke2019; : 345 doi: 10.1002/9781118492390.ch7
56
Mohamed Shengir, Mohamed Elgara, Giada Sebastiani. Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyondWorld Journal of Gastroenterology 2021; 27(17): 1959-1972 doi: 10.3748/wjg.v27.i17.1959
57
Ivan Gentile, Emanuela Zappulo, Antonio Riccardo Buonomo, Alberto Enrico Maraolo, Guglielmo Borgia. Beclabuvir for the treatment of hepatitis CExpert Opinion on Investigational Drugs 2015; 24(8): 1111 doi: 10.1517/13543784.2015.1059820
58
Patrice Cacoub, Cloé Comarmond. New insights into HCV-related rheumatologic disorders: A reviewJournal of Advanced Research 2017; 8(2): 89 doi: 10.1016/j.jare.2016.07.005
59
Fabrizio Fabrizi, Piergiorgio Messa. Managing hepatitis C therapy failures and chronic kidney diseaseExpert Review of Clinical Pharmacology 2018; 11(11): 1135 doi: 10.1080/17512433.2018.1534202
60
Xin Su, Xin Zhao, Jia‐Long Deng, Song‐Nan Li, Xin Du, Jian‐Zeng Dong, Chang‐Sheng Ma. Antiviral treatment for hepatitis C is associated with a reduced risk of atherosclerotic cardiovascular outcomes: A systematic review and meta‐analysisJournal of Viral Hepatitis 2021; 28(4): 664 doi: 10.1111/jvh.13469
61
Çetin Karaca. Viral Hepatitis: Chronic Hepatitis C2019; : 183 doi: 10.1007/978-3-030-03757-4_10
62
Fanny Domont, Patrice Cacoub. Chronic hepatitis C virus infection, a new cardiovascular risk factor?Liver International 2016; 36(5): 621 doi: 10.1111/liv.13064
63
M L Zubkin, V I Chervinko, Yu V Ovchinnikov, E V Kryukov, O N Kotenko. Chronic HCV infection: An internist’s opinion (Part 2)Terapevticheskii arkhiv 2016; 88(11): 138 doi: 10.17116/terarkh20168811138-148
64
Jing-Hua Li, Ning Zhu, Ying-Bin Min, Xiang-Zhou Shi, Yun-You Duan, Yi-Lin Yang. Ultrasonic assessment of liver stiffness and carotid artery elasticity in patients with chronic viral hepatitisBMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0910-z
65
Salvatore Petta. Hepatitis C virus and cardiovascular: A reviewJournal of Advanced Research 2017; 8(2): 161 doi: 10.1016/j.jare.2016.06.001
66
Hamdy A. Sliem, Ahmed S. Salem, Walid M. Hussien, Hind R.A. El Sayed. Arterial wall structural changes in noncirrhotic chronic hepatitis C patientsEuropean Journal of Gastroenterology & Hepatology 2019; 31(11): 1432 doi: 10.1097/MEG.0000000000001429
67
Luca Rinaldi, Fabio Nascimbeni, Mauro Giordano, Chiara Masetti, Barbara Guerrera, Annalisa Amelia, Maria Chiara Fascione, Stefano Ballestri, Dante Romagnoli, Rosa Zampino, Riccardo Nevola, Enrica Baldelli, Natalina Iuliano, Valerio Rosato, Amedeo Lonardo, Luigi Elio Adinolfi. Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosisWorld Journal of Gastroenterology 2017; 23(8): 1458-1468 doi: 10.3748/wjg.v23.i8.1458
68
Cristina Vassalle, Antonella Meloni, Laura Pistoia, Alessia Pepe. LIVER PANCREAS HEART TRIANGLE AND HCV IN THALASSEMIA: EXPANDING THE HORIZON THROUGH BIOMARKER NETWORKSInternational Journal of Hematology and Therapy 2017; 3(1): 1 doi: 10.15436/2381-1404.17.017
69
Silvana Zito, Simona Mercurio, Giuseppe Mercurio, Alessandro Pigoni, Gian Mario Mandolini, Elisabetta Caletti. Neurocognitive impairment and cerebral metabolic alterations induced by direct hepatitis C virus neuroinvasion: implications on quality of lifeMinerva Psichiatrica 2019; 60(2) doi: 10.23736/S0391-1772.19.02012-0
70
Patrice Cacoub, Anne Claire Desbois, Cloe Comarmond, David Saadoun. Impact of sustained virological response on the extrahepatic manifestations of chronic hepatitis C: a meta-analysisGut 2018; 67(11): 2025 doi: 10.1136/gutjnl-2018-316234
71
Javier Ampuero, Manuel Romero-Gómez. Assessing cardiovascular risk in hepatitis C: An unmet needWorld Journal of Hepatology 2015; 7(19): 2214-2219 doi: 10.4254/wjh.v7.i19.2214
72
Patrice Cacoub, Laura Gragnani, Cloe Comarmond, Anna Linda Zignego. Extrahepatic manifestations of chronic hepatitis C virus infectionDigestive and Liver Disease 2014; 46: S165 doi: 10.1016/j.dld.2014.10.005
73
José M. Ferro, Pedro Viana, Patrícia Santos. Management of Neurologic Manifestations in Patients with Liver DiseaseCurrent Treatment Options in Neurology 2016; 18(8) doi: 10.1007/s11940-016-0419-0
74
Hope Onohuean, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Safaa Qusti, Eida M. Alshammari, Gaber El-Saber Batiha. Covid-19 and development of heart failure: mystery and truthNaunyn-Schmiedeberg's Archives of Pharmacology 2021; 394(10): 2013 doi: 10.1007/s00210-021-02147-6
75
Tao Zhang, Yuan Jiang, Shuhua Zhang, Tingting Tie, Yan Cheng, Xiaoming Su, Zhu Man, Jing Hou, Li Sun, Meiyuan Tian, Yaogang Zhang, Jianhua Li, Yanyan Ma. The association between homocysteine and ischemic stroke subtypes in ChineseMedicine 2020; 99(12): e19467 doi: 10.1097/MD.0000000000019467
76
Fabrizio Fabrizi, Francesca M. Donato, Piergiorgio Messa. Hepatitis C and Its Metabolic Complications in Kidney DiseaseAnnals of Hepatology 2017; 16(6): 851 doi: 10.5604/01.3001.0010.5275
77
Luigi Elio Adinolfi, Riccardo Nevola, Giacomo Lus, Luciano Restivo, Barbara Guerrera, Ciro Romano, Rosa Zampino, Luca Rinaldi, Ausilia Sellitto, Mauro Giordano, Aldo Marrone. Chronic hepatitis C virus infection and neurological and psychiatric disorders: An overviewWorld Journal of Gastroenterology 2015; 21(8): 2269-2280 doi: 10.3748/wjg.v21.i8.2269
78
Anna Linda Zignego, Manuel Ramos-Casals, Clodoveo Ferri, David Saadoun, Luca Arcaini, Dario Roccatello, Alessandro Antonelli, Anne Claire Desbois, Cloe Comarmond, Laura Gragnani, Milvia Casato, Peter Lamprecht, Alessandra Mangia, Athanasios G Tzioufas, Zobair M Younossi, Patrice Cacoub. International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statementAutoimmunity Reviews 2017; 16(5): 523 doi: 10.1016/j.autrev.2017.03.004
79
Sara C. LaHue, Dolores Torres, Nicole Rosendale, Vineeta Singh. Stroke Characteristics, Risk Factors, and Outcomes in Transgender AdultsThe Neurologist 2019; 24(2): 66 doi: 10.1097/NRL.0000000000000226
80
Dante Romagnoli, Alessandra Marrazzo, Stefano Ballestri, Amedeo Lonardo, Marco Bertolotti. Sofosbuvir-based therapy cures hepatitis C virus infection after prior treatment failures in a patient with concurrent lymphomaJournal of Clinical Virology 2015; 69: 74 doi: 10.1016/j.jcv.2015.05.023
81
Roberto Minutolo, Alessio Aghemo, Antonio Chirianni, Fabrizio Fabrizi, Loreto Gesualdo, Edoardo G. Giannini, Paolo Maggi, Vincenzo Montinaro, Ernesto Paoletti, Marcello Persico, Francesco Perticone, Salvatore Petta, Massimo Puoti, Giovanni Raimondo, Maria Rendina, Anna Linda Zignego. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN)Digestive and Liver Disease 2018; 50(11): 1133 doi: 10.1016/j.dld.2018.08.022
82
Roberto Minutolo, Alessio Aghemo, Antonio Chirianni, Fabrizio Fabrizi, Loreto Gesualdo, Edoardo G. Giannini, Paolo Maggi, Vincenzo Montinaro, Ernesto Paoletti, Marcello Persico, Francesco Perticone, Salvatore Petta, Massimo Puoti, Giovanni Raimondo, Maria Rendina, Anna Linda Zignego. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN)Internal and Emergency Medicine 2018; 13(8): 1139 doi: 10.1007/s11739-018-1940-9
83
Clodoveo Ferri, Manuel Ramos-Casals, Anna Linda Zignego, Luca Arcaini, Dario Roccatello, Alessandro Antonelli, David Saadoun, Anne Claire Desbois, Marco Sebastiani, Milvia Casato, Peter Lamprecht, Alessandra Mangia, Athanasios G Tzioufas, Zobair M Younossi, Patrice Cacoub. International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statementAutoimmunity Reviews 2016; 15(12): 1145 doi: 10.1016/j.autrev.2016.09.006
84
Amilcar L Morales, Zachary Junga, Manish B Singla, Maria Sjogren, Dawn Torres. Hepatitis C eradication with sofosbuvir leads to significant metabolic changesWorld Journal of Hepatology 2016; 8(35): 1557-1563 doi: 10.4254/wjh.v8.i35.1557
85
He Huang, Rongyan Kang, Zhendong Zhao, Yury E. Khudyakov. Is Hepatitis C Associated with Atherosclerotic Burden? A Systematic Review and Meta-AnalysisPLoS ONE 2014; 9(9): e106376 doi: 10.1371/journal.pone.0106376
86
Claudia Mascia, Miriam Lichtner, Paola Zuccalà, Serena Vita, Tiziana Tieghi, Raffaella Marocco, Stefano Savinelli, Raffaella Rossi, Marco Iannetta, Michela Campagna, Francesco Schiavone, Fabio Mengoni, Gianluca Russo, Claudio Maria Mastroianni, Vincenzo Vullo. Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfectionClinics and Research in Hepatology and Gastroenterology 2017; 41(6): 644 doi: 10.1016/j.clinre.2017.04.007
87
Michael Broker, Shalom Z. Frager, Nayan S. Patel, Edward Lebovics, William H. Frishman. The Inflammatory Relationship Between Hepatitis C Virus With Coronary and Carotid AtherosclerosisCardiology in Review 2021; 29(4): 178 doi: 10.1097/CRD.0000000000000314
88
Maria Perticone, Raffaele Maio, Eliezer Joseph Tassone, Giovanni Tripepi, Serena Di Cello, Sofia Miceli, Benedetto Caroleo, Angela Sciacqua, Anna Licata, Giorgio Sesti, Francesco Perticone. Insulin-resistance HCV infection-related affects vascular stiffness in normotensivesAtherosclerosis 2015; 238(1): 108 doi: 10.1016/j.atherosclerosis.2014.11.025
89
Giovanni Targher, Christopher D. Byrne. Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney diseaseNature Reviews Nephrology 2017; 13(5): 297 doi: 10.1038/nrneph.2017.16
90
Fernando Scudiero, Renato Valenti, Rossella Marcucci, Giuseppe D. Sanna, Anna Maria Gori, Angela Migliorini, Raffaele Vitale, Betti Giusti, Elena De Vito, Giulia Corda, Rita Paniccia, Davide Zirolia, Mario E. Canonico, Guido Parodi. Platelet Reactivity in Hepatitis C Virus–Infected Patients on Dual Antiplatelet Therapy for Acute Coronary SyndromeJournal of the American Heart Association 2020; 9(18) doi: 10.1161/JAHA.120.016441
91
Ciro Romano, Giovanna Cuomo, Roberta Ferrara, Andrea Del Mastro, Sergio Esposito, Ausilia Sellitto, Luigi Elio Adinolfi. Uncommon immune-mediated extrahepatic manifestations of HCV infectionExpert Review of Clinical Immunology 2018; 14(12): 1089 doi: 10.1080/1744666X.2018.1538790
92
Theodoros Voulgaris, Vassilios A. Sevastianos. Atherosclerosis as Extrahepatic Manifestation of Chronic Infection with Hepatitis C VirusHepatitis Research and Treatment 2016; 2016: 1 doi: 10.1155/2016/7629318
93
Kristine S. Alexander, Neil A. Zakai, Steven D. Lidofsky, Peter W. Callas, Suzanne E. Judd, Russell P. Tracy, Mary Cushman, Pavel Strnad. Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohortPLOS ONE 2018; 13(3): e0194153 doi: 10.1371/journal.pone.0194153
94
Patrice Cacoub, Pierre Nahon, Richard Layese, Lorraine Blaise, Anne Claire Desbois, Valérie Bourcier, Carole Cagnot, Patrick Marcellin, Dominique Guyader, Stanislas Pol, Dominique Larrey, Victor De Lédinghen, Denis Ouzan, Fabien Zoulim, Dominique Roulot, Albert Tran, Jean-Pierre Bronowicki, Jean-Pierre Zarski, Ghassan Riachi, Paul Calès, Jean-Marie Péron, Laurent Alric, Marc Bourlière, Philippe Mathurin, Jean-Frédéric Blanc, Armand Abergel, Lawrence Serfaty, Ariane Mallat, Jean-Didier Grangé, Pierre Attali, Yannick Bacq, Claire Wartelle, Thông Dao, Dominique Thabut, Christophe Pilette, Christine Silvain, Christos Christidis, Dominique Capron, Gérard Thiefin, David Zucman, Vincent Di Martino, Corinne Isnard Bagnis, Marianne Ziol, Angela Sutton, Eric Letouze, Françoise Roudot-Thoraval, Etienne Audureau, Pierre Nahon, Patrick Marcellin, Dominique Guyader, Stanislas Pol, Hélène Fontaine, Dominique Larrey, Victor De Lédinghen, Denis Ouzan, Fabien Zoulim, Dominique Roulot, Albert Tran, Jean-Pierre Bronowicki, Jean-Pierre Zarski, Vincent Leroy, Ghassan Riachi, Paul Calès, Jean-Marie Péron, Laurent Alric, Marc Bourlière, Philippe Mathurin, Sebastien Dharancy, Jean-Frédéric Blanc, Armand Abergel, Lawrence Serfaty, Ariane Mallat, Jean-Didier Grangé, Pierre Attali, Yannick Bacq, Claire Wartelle, Thông Dao, Yves Benhamou, Christophe Pilette, Christine Silvain, Christos Christidis, Dominique Capron, Gérard Thiefin, Sophie Hillaire, Vincent Di Martino. Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patientsAmerican Heart Journal 2018; 198: 4 doi: 10.1016/j.ahj.2017.10.024
95
Timothy C Durazzo, Linh-Chi Nguyen, Dieter J Meyerhoff. Medical Conditions Linked to Atherosclerosis Are Associated With Magnified Cortical Thinning in Individuals With Alcohol Use DisordersAlcohol and Alcoholism 2020; 55(4): 382 doi: 10.1093/alcalc/agaa034
96
Shilu Mathew, Muhammed Faheem, Sara M Ibrahim, Waqas Iqbal, Bisma Rauff, Kaneez Fatima, Ishtiaq Qadri. Hepatitis C virus and neurological damageWorld Journal of Hepatology 2016; 8(12): 545-556 doi: 10.4254/wjh.v8.i12.545
97
Patrice Cacoub, Cloe Comarmond, Fanny Domont, Léa Savey, Anne C. Desbois, David Saadoun. Extrahepatic manifestations of chronic hepatitis C virus infectionTherapeutic Advances in Infectious Disease 2016; 3(1): 3 doi: 10.1177/2049936115585942
98
Alex Reyentovich, Claudia G. Gidea, Deane Smith, Bonnie Lonze, Zachary Kon, Anthony Fargnoli, Jennifer Pavone, Shaline Rao, Tajinderpal Saraon, Tyler Lewis, Yingzhi Qian, Ira Jacobson, Nader Moazami. Outcomes of the Treatment with Glecaprevir/Pibrentasvir following heart transplantation utilizing hepatitis C viremic donorsClinical Transplantation 2020; 34(9) doi: 10.1111/ctr.13989
99
Javier Pagan, Marco Ladino, David Roth. Treating hepatitis C virus in dialysis patients: How, when, and why?Seminars in Dialysis 2019; 32(2): 152 doi: 10.1111/sdi.12764
100
Arpan Mohanty, Sarah Salameh, Adeel A. Butt. Impact of Direct Acting Antiviral Agent Therapy upon Extrahepatic Manifestations of Hepatitis C Virus InfectionCurrent HIV/AIDS Reports 2019; 16(5): 389 doi: 10.1007/s11904-019-00466-1
101
Ming V. Lin, Meghan E. Sise, Martha Pavlakis, Beth M. Amundsen, Donald Chute, Anna E. Rutherford, Raymond T. Chung, Michael P. Curry, Jasmine M. Hanifi, Steve Gabardi, Anil Chandraker, Eliot C. Heher, Nahel Elias, Leonardo V. Riella, Chen-Hua Liu. Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus InfectionPLOS ONE 2016; 11(7): e0158431 doi: 10.1371/journal.pone.0158431
102
Maria M. Xu, Patrick A. Murphy, Anthony T. Vella. Activated T-effector seeds: cultivating atherosclerotic plaque through alternative activationAmerican Journal of Physiology-Heart and Circulatory Physiology 2019; 316(6): H1354 doi: 10.1152/ajpheart.00148.2019
103
Simona Cammarota, Anna Citarella, Antonella Guida, Valeria Conti, Teresa Iannaccone, Maria Elena Flacco, Francesca Bravi, Cristina Naccarato, Antonella Piscitelli, Raffaele Piscitelli, Alfredo Valente, Giulio Calella, Nicola Coppola, Giustino Parruti, Yury E Khudyakov. The inpatient hospital burden of comorbidities in HCV-infected patients: A population-based study in two Italian regions with high HCV endemicity (The BaCH study)PLOS ONE 2019; 14(7): e0219396 doi: 10.1371/journal.pone.0219396
104
Juan Berenguer, Elena Rodríguez-Castellano, Ana Carrero, Miguel A. Von Wichmann, Marta Montero, María J. Galindo, Josep Mallolas, Manuel Crespo, María J. Téllez, Carmen Quereda, José Sanz, Carlos Barros, Cristina Tural, Ignacio Santos, Federico Pulido, Josep M. Guardiola, Rafael Rubio, Enrique Ortega, María L. Montes, Juan J. Jusdado, Gabriel Gaspar, Herminia Esteban, José M. Bellón, Juan González-García. Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus/hepatitis C virus coinfectionHepatology 2017; 66(2): 344 doi: 10.1002/hep.29071
105
Kazuhiro Osawa, Toru Miyoshi, Kentarou Yamauchi, Yasushi Koyama, Kazufumi Nakamura, Shuhei Sato, Susumu Kanazawa, Hiroshi Ito, Giovanni Targher. Nonalcoholic Hepatic Steatosis Is a Strong Predictor of High-Risk Coronary-Artery Plaques as Determined by Multidetector CTPLOS ONE 2015; 10(6): e0131138 doi: 10.1371/journal.pone.0131138
106
Experimental and Clinical Transplantation 2017; 15(1) doi: 10.6002/ect.2015.0341
107
Patrice Cacoub, Cloé Comarmond. Considering hepatitis C virus infection as a systemic diseaseSeminars in Dialysis 2018;  doi: 10.1111/sdi.12758
108
Dalia A Freekh, Maged W Helmy, Mohamed Said, Noha M El-khodary. The effect of direct acting antiviral agents on vascular endothelial function in Egyptian patients with chronic hepatitis C virus infectionSaudi Pharmaceutical Journal 2021;  doi: 10.1016/j.jsps.2021.08.006